GLP

美 　英

• 網(wǎng)絡(luò)優(yōu)良實驗室規(guī)范(Good Laboratory Practice)；良好實驗室規(guī)范；普洛斯(Global Logistic Properties)

例句

This is not just a confused individual pretending to be the returned Christ, there are lots of those including a few on GLP too.

這不僅是一個混亂的個體，假裝要返回的基督，也有包括GLP的幾個地段。

Objective It was a reference for GLP laboratory to develop standard operating procedures(SOP) of instruments and equipment.

目的為GLP實驗室制定儀器設(shè)備的標準操作規(guī)程（SOP）提供參考。

CONCLUSIONS Weight reduction with GLP-1 receptor agonists was associated with a shift toward a more favorable cardiovascular risk profile.

結(jié)論：GLP-1受體激動劑治療后的體重減輕與心血管危險因素譜向更有益的方向轉(zhuǎn)變有關(guān)。

Dr Munger, though, found that both GLP-1 and the receptor molecule that picks it up and thus allows it to act are found in taste buds too.

而芒杰博士發(fā)現(xiàn)，在味蕾中也有GLP-1和接收GLP-1并使其發(fā)生作用的受體的存在。

Deteriorations in glucose homeostasis can develop in the absence of any impairment in GIP or GLP-1 levels.

在GIP和GLP-1水平沒有受損的情況下，葡萄糖穩(wěn)態(tài)仍不斷被破壞。

This increase in GLP-1 secretion may be mediated via stimulation of sweet-taste receptors on L-cells by artificial sweetener.

GLP-1分泌增加是通過人工甜味劑刺激L細胞上的甜味受體調(diào)節(jié)的。

This phenomenon is called the incretin effect and is caused by the two incretin hormones GIP and GLP-1.

這種現(xiàn)象被稱為腸效應(yīng)和所造成的兩個腸肽激素和GLP-1。

Dipeptidyl peptidase (DPP-IV) inhibitors suppress the degradation of many peptides, including GLP-1, thereby extending their bioactivity.

二肽酶（民進黨四）抑制劑抑制多肽降解，包括血糖素樣肽1，從而延長它們的生物活性。

Product triphen in GLP is light hydrocarbon aromatization technique in A petrochemical field.

液化氣芳構(gòu)化生產(chǎn)三苯工藝，屬于石化領(lǐng)域輕烴芳構(gòu)化技術(shù)。

Ensure the rules of GMP and GLP had been followed in QC department.

負責GMP和GLP規(guī)范在本部門得到很好的實施。

To promote the medical device GLP to be carried out and provide reference for the medical device evaluation personnel.

為我國推行醫(yī)療器械GLP以及為從事醫(yī)療器械檢測檢驗的實驗人員提供參考。

Conclusions: Orlistat alters gastric and gallbladder emptying and reduces the postprandial secretion of GLP-1, PYY and CCK.

結(jié)論：奧利斯特改變了胃和膽囊排空，并減少GLP-1，PYY和CCK的餐后分泌。

Consequently, the intracerebral glucose concentration remained constant in all regions, with and without GLP-1.

因此，用或不用GLP-1腦內(nèi)所有區(qū)域葡萄糖濃度均保持恒定。

Conclusion GLP-1 analog can paly an important role in treatment of experimental diabetes mellitus through multiple ways.

結(jié)論：GLP-1類似物可以通過多種途徑在治療實驗性糖尿病中發(fā)揮作用。

however, the cardiovascular effects of distinct GLP-1 peptides have received limited attention.

然而不同的胰高血糖素樣肽1對心血管的效應(yīng)卻很少被關(guān)注。

We don't know who will benefit more from these drugs but I use GLP-1 therapy very often in many patients and they tolerate it fine.

我們不知道誰可以從此類藥物中獲益更多，但是我在許多患者中非常普遍的使用GLP-1治療，而且他們耐受良好。

Inhibition of GLP-1 signaling with exenatide blocks some of the effects of gastric bypass but not others.

用艾塞那肽抑制GLP-1信號途徑阻斷胃旁路術(shù)的某些影響，但其他影響則未阻斷。

For ISE measurements, an ionic strength constant value is stored with GLP data.

對于ISE測量，離子強度常數(shù)與GLP數(shù)據(jù)一同存儲。

CONCLUSIONS Artificial sweeteners synergize with glucose to enhance GLP-1 release in humans.

結(jié)論在人類，人工甜味劑和葡萄糖協(xié)調(diào)合作增加GLP-1的分泌。

There are many challenges in developing an oral formulation of GLP-1, in particular obtaining adequate bioavailability.

開發(fā)口服型的GLP-1藥物存在許多難題，尤其是需要有足夠的生物利用度。

What do you think of the role of GLP-1 in diabetes in the US?

您如何看待GLP-1在美國糖尿病治療中的地位？

Conclusion GLP-2 can promote recovery of small intestinal epithelia from radiation injury in mice.

結(jié)論胰高血糖素樣肽-2可促進放射損傷小鼠腸上皮的恢復。

To investigate the therapeutic effects of glucagon-like peptide-1 (GLP-1) analog on rats with experimental diabetes mellitus.

目的：探討胰高血糖素樣肽-1（GLP-1）類似物對實驗性糖尿病的治療作用。

GLP helps the research products win a higher economic value.

GLP可以使產(chǎn)品研發(fā)的經(jīng)濟價值有數(shù)量級的提升；

In generally, we have different strategies to prolong the action of the GLP 1.

一般而言，我們采用以下幾種策略延長GLP-1的作用時間。

By increasing levels of GLP-1 the medicine could improve the imbalance between insulin and glucose that causes type 2 diabetes.

該藥物增加GLP-1的水平能夠改善胰島素和胰高血糖素的不平衡，此種不平衡引發(fā)了糖尿病。

I would choose in this order metformin, pioglitazone, GLP-1 compound and then insulin.

我會按照這樣的順序選擇，二甲雙胍，吡格列酮，GLP-1類藥物，然后才是胰島素。

Consistent with this, central application of GLP-2 activates the expression of neurons solely in the DMH.

據(jù)此，中央應(yīng)用肽-2激活的神經(jīng)元的表達只在分部。

To investigate GLP-1's role in taste, the team used a strain of mice that were genetically engineered to lack GLP-1 receptors.

為了弄清GLP-1在味覺中的作用，該研究小組使用了一組通過基因改造而缺失GLP-1受體的老鼠。

Patients with kidney failure should not be treated with GLP-1 because data from trials are not yet here.

由于目前尚沒有試驗數(shù)據(jù)，腎衰患者不應(yīng)該使用GLP-1治療。

Glucagon-like peptide-1 is a polypeptide hormone, which is secreted from L cell of the intestine.

胰高血糖素樣肽-1（GLP-1）是由腸道L細胞分泌的一種多肽激素。

GLP-1 can increase insulin secretion, suppress the level of glucose in the blood and inhibit ingestion.

GLP-1能促胰島素分泌，降低血糖水平和抑制采食等。

Recent research in rodents suggests a protective effect of GLP-1 on brain tissue.

最近在嚙齒類中的研究表明GLP-1對腦組織起保護作用。

To check all GLP program and all final test reports.

GLP試驗計劃審核及最終報告審核。

GLP-1 (Glucagon-Like Peptide-1) is a natural hormone involved in controlling blood sugar levels.

（胰高血糖素樣肽-1）是一種天然的調(diào)節(jié)血糖水平的激素。

However GLP-1 receptors are abundant in many other tissues.

然而GLP-1受體在其他組織同樣大量存在。

I see lots of cute stories now and then on GLP about people's kids who remember and even know why they are here.

在GLP論壇上，我時常看到很多可愛的故事，關(guān)于人們的小孩有著前世記憶，甚至知道他們為何在這里。

BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.

百泌達是FDA批準的治療2型糖尿病的首個GLP-1受體激動劑藥物。

GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

GLP-1通過同時作用于腸道、肝臟、胰腺和大腦等多種機制改善餐后血糖。

Defects in glucagon-like peptide 1 (GLP-1) secretion have been reported in some patients with type 2 diabetes after meal ingestion.

一些2型糖尿病患者餐后胰高血糖素樣肽-1（GLP-1）分泌缺乏先前已有報道。